APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Long-acting Reversible Contraceptives (LARCs)

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Long-acting Reversible Contraceptives (LARCs) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 17442606024 July 2026197 pages

Choose your research edition.

Industry ResearchLong-acting Reversible Contraceptives (LARCs) Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Long-acting Reversible Contraceptives (LARCs) Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Long-acting Reversible Contraceptives (LARCs) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Long-acting Reversible Contraceptives (LARCs) Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Long-acting Reversible Contraceptives (LARCs) Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Long-acting Reversible Contraceptives (LARCs) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Long-acting Reversible Contraceptives (LARCs) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Long-acting Reversible Contraceptives (LARCs) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Long-acting Reversible Contraceptives (LARCs) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Long-acting Reversible Contraceptives (LARCs) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Long-acting Reversible Contraceptives (LARCs) include AbbVie Allergan, ASPIVIX, Cooper Companies, Durbin, H & J Medical, HRA Pharma, Laboratoire 7 MED, Laboratoire CCD and OCON, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Long-acting Reversible Contraceptives (LARCs) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Long-acting Reversible Contraceptives (LARCs) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Long-acting Reversible Contraceptives (LARCs) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Long-acting Reversible Contraceptives (LARCs) market size, projected growth trends, production technologies, key applications, and end-use industries.

Long-acting Reversible Contraceptives (LARCs) Segment by Company

AbbVie Allergan

ASPIVIX

Cooper Companies

Durbin

H & J Medical

HRA Pharma

Laboratoire 7 MED

Laboratoire CCD

OCON

Pregna

Prosan

Shanghai Dahua Pharmaceuticals

Williams Medical Supplies

Yantai JiShengYaoXie

Bayer

Merck

Long-acting Reversible Contraceptives (LARCs) Segment by Type

Copper Intrauterine Devices

Hormonal Intrauterine Devices

Contraceptive Implants

Others

Long-acting Reversible Contraceptives (LARCs) Segment by Application

Age 20-24

Age 25-34

Age 35-44

Others

Long-acting Reversible Contraceptives (LARCs) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Long-acting Reversible Contraceptives (LARCs) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Long-acting Reversible Contraceptives (LARCs) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Long-acting Reversible Contraceptives (LARCs).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Long-acting Reversible Contraceptives (LARCs) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Long-acting Reversible Contraceptives (LARCs) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Long-acting Reversible Contraceptives (LARCs) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Long-acting Reversible Contraceptives (LARCs) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Long-acting Reversible Contraceptives (LARCs) Industry Trends Table 2. Long-acting Reversible Contraceptives (LARCs) Industry Drivers Table 3. Long-acting Reversible Contraceptives (LARCs) Industry Opportunities and Challenges Table 4. Long-acting Reversible Contraceptives (LARCs) Industry Restraints Table 5. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Long-acting Reversible Contraceptives (LARCs) Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Manufacturers Table 9. Global Long-acting Reversible Contraceptives (LARCs) Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Long-acting Reversible Contraceptives (LARCs) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Long-acting Reversible Contraceptives (LARCs) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Long-acting Reversible Contraceptives (LARCs) Manufacturers, Product Type & Application Table 13. Global Long-acting Reversible Contraceptives (LARCs) Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Long-acting Reversible Contraceptives (LARCs) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Copper Intrauterine Devices Table 17. Major Manufacturers of Hormonal Intrauterine Devices Table 18. Major Manufacturers of Contraceptive Implants Table 19. Major Manufacturers of Others Table 20. Global Long-acting Reversible Contraceptives (LARCs) Sales by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Long-acting Reversible Contraceptives (LARCs) Sales by Type (2021-2026) & (k units) Table 22. Global Long-acting Reversible Contraceptives (LARCs) Sales by Type (2027-2032) & (k units) Table 23. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type (2021-2026) Table 24. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type (2027-2032) Table 25. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 26. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2021-2026) & (k units) Table 27. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2027-2032) & (k units) Table 28. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Type (2021-2026) Table 29. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Age 20-24 Table 31. Major Manufacturers of Age 25-34 Table 32. Major Manufacturers of Age 35-44 Table 33. Major Manufacturers of Others Table 34. Global Long-acting Reversible Contraceptives (LARCs) Sales by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Long-acting Reversible Contraceptives (LARCs) Sales by Application (2021-2026) & (k units) Table 36. Global Long-acting Reversible Contraceptives (LARCs) Sales by Application (2027-2032) & (k units) Table 37. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application (2021-2026) Table 38. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application (2027-2032) Table 39. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 40. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2021-2026) & (k units) Table 41. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2027-2032) & (k units) Table 42. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Application (2021-2026) Table 43. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Application (2027-2032) Table 44. Global Long-acting Reversible Contraceptives (LARCs) Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Long-acting Reversible Contraceptives (LARCs) Sales by Region (2021-2026) & (k units) Table 46. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Region (2021-2026) Table 47. Global Long-acting Reversible Contraceptives (LARCs) Sales Forecasted by Region (2027-2032) & (k units) Table 48. Global Long-acting Reversible Contraceptives (LARCs) Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Long-acting Reversible Contraceptives (LARCs) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. North America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2021-2026) & (k units) Table 51. North America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2027-2032) & (k units) Table 52. Europe Long-acting Reversible Contraceptives (LARCs) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Country (2021-2026) & (k units) Table 54. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Country (2027-2032) & (k units) Table 55. Asia Pacific Long-acting Reversible Contraceptives (LARCs) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Asia Pacific Long-acting Reversible Contraceptives (LARCs) Sales by Country (2021-2026) & (k units) Table 57. Asia Pacific Long-acting Reversible Contraceptives (LARCs) Sales by Country (2027-2032) & (k units) Table 58. South America, Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 59. South America, Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales by Country (2021-2026) & (k units) Table 60. South America, Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales by Country (2027-2032) & (k units) Table 61. Global Long-acting Reversible Contraceptives (LARCs) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Region (2021-2026) Table 65. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Region (2027-2032) Table 66. AbbVie Allergan Company Information Table 67. AbbVie Allergan Business Overview Table 68. AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 70. AbbVie Allergan Recent Development Table 71. ASPIVIX Company Information Table 72. ASPIVIX Business Overview Table 73. ASPIVIX Long-acting Reversible Contraceptives (LARCs) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. ASPIVIX Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 75. ASPIVIX Recent Development Table 76. Cooper Companies Company Information Table 77. Cooper Companies Business Overview Table 78. Cooper Companies Long-acting Reversible Contraceptives (LARCs) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Cooper Companies Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 80. Cooper Companies Recent Development Table 81. Durbin Company Information Table 82. Durbin Business Overview Table 83. Durbin Long-acting Reversible Contraceptives (LARCs) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Durbin Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 85. Durbin Recent Development Table 86. H & J Medical Company Information Table 87. H & J Medical Business Overview Table 88. H & J Medical Long-acting Reversible Contraceptives (LARCs) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. H & J Medical Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 90. H & J Medical Recent Development Table 91. HRA Pharma Company Information Table 92. HRA Pharma Business Overview Table 93. HRA Pharma Long-acting Reversible Contraceptives (LARCs) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. HRA Pharma Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 95. HRA Pharma Recent Development Table 96. Laboratoire 7 MED Company Information Table 97. Laboratoire 7 MED Business Overview Table 98. Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 100. Laboratoire 7 MED Recent Development Table 101. Laboratoire CCD Company Information Table 102. Laboratoire CCD Business Overview Table 103. Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 105. Laboratoire CCD Recent Development Table 106. OCON Company Information Table 107. OCON Business Overview Table 108. OCON Long-acting Reversible Contraceptives (LARCs) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. OCON Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 110. OCON Recent Development Table 111. Pregna Company Information Table 112. Pregna Business Overview Table 113. Pregna Long-acting Reversible Contraceptives (LARCs) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Pregna Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 115. Pregna Recent Development Table 116. Prosan Company Information Table 117. Prosan Business Overview Table 118. Prosan Long-acting Reversible Contraceptives (LARCs) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. Prosan Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 120. Prosan Recent Development Table 121. Shanghai Dahua Pharmaceuticals Company Information Table 122. Shanghai Dahua Pharmaceuticals Business Overview Table 123. Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 125. Shanghai Dahua Pharmaceuticals Recent Development Table 126. Williams Medical Supplies Company Information Table 127. Williams Medical Supplies Business Overview Table 128. Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 130. Williams Medical Supplies Recent Development Table 131. Yantai JiShengYaoXie Company Information Table 132. Yantai JiShengYaoXie Business Overview Table 133. Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 134. Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 135. Yantai JiShengYaoXie Recent Development Table 136. Bayer Company Information Table 137. Bayer Business Overview Table 138. Bayer Long-acting Reversible Contraceptives (LARCs) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 139. Bayer Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 140. Bayer Recent Development Table 141. Merck Company Information Table 142. Merck Business Overview Table 143. Merck Long-acting Reversible Contraceptives (LARCs) Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 144. Merck Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 145. Merck Recent Development Table 146. Key Raw Materials Table 147. Raw Materials Key Suppliers Table 148. Long-acting Reversible Contraceptives (LARCs) Distributors List Table 149. Long-acting Reversible Contraceptives (LARCs) Customers List Table 150. Research Programs/Design for This Report Table 151. Authors List of This Report Table 152. Secondary Sources Table 153. Primary Sources List of Figures Figure 1. Long-acting Reversible Contraceptives (LARCs) Product Image Figure 2. Global Long-acting Reversible Contraceptives (LARCs) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Long-acting Reversible Contraceptives (LARCs) Market Size (2021-2032) & (US$ Million) Figure 4. Global Long-acting Reversible Contraceptives (LARCs) Sales (2021-2032) & (k units) Figure 5. Global Long-acting Reversible Contraceptives (LARCs) Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Long-acting Reversible Contraceptives (LARCs) Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Copper Intrauterine Devices Image Figure 9. Hormonal Intrauterine Devices Image Figure 10. Contraceptive Implants Image Figure 11. Others Image Figure 12. Global Long-acting Reversible Contraceptives (LARCs) Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type (2021-2032) Figure 15. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Type (2021-2032) Figure 18. Age 20-24 Image Figure 19. Age 25-34 Image Figure 20. Age 35-44 Image Figure 21. Others Image Figure 22. Global Long-acting Reversible Contraceptives (LARCs) Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application (2021-2032) Figure 25. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 26. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Application (2021-2032) Figure 28. North America Long-acting Reversible Contraceptives (LARCs) Sales and Growth Rate (2021-2032) & (k units) Figure 29. North America Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Country (2021-2032) Figure 30. U.S. Long-acting Reversible Contraceptives (LARCs) Sales and Growth Rate (2021-2032) & (k units) Figure 31. Canada Long-acting Reversible Contraceptives (LARCs) Sales and Growth Rate (2021-2032) & (k units) Figure 32. Mexico Long-acting Reversible Contraceptives (LARCs) Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Long-acting Reversible Contraceptives (LARCs) Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Country (2021-2032) Figure 35. Germany Long-acting Reversible Contraceptives (LARCs) Sales and Growth Rate (2021-2032) & (k units) Figure 36. France Long-acting Reversible Contraceptives (LARCs) Sales and Growth Rate (2021-2032) & (k units) Figure 37. U.K. Long-acting Reversible Contraceptives (LARCs) Sales and Growth Rate (2021-2032) & (k units) Figure 38. Italy Long-acting Reversible Contraceptives (LARCs) Sales and Growth Rate (2021-2032) & (k units) Figure 39. Netherlands Long-acting Reversible Contraceptives (LARCs) Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Long-acting Reversible Contraceptives (LARCs) Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Country (2021-2032) Figure 42. China Long-acting Reversible Contraceptives (LARCs) Sales and Growth Rate (2021-2032) & (k units) Figure 43. Japan Long-acting Reversible Contraceptives (LARCs) Sales and Growth Rate (2021-2032) & (k units) Figure 44. South Korea Long-acting Reversible Contraceptives (LARCs) Sales and Growth Rate (2021-2032) & (k units) Figure 45. Southeast Asia Long-acting Reversible Contraceptives (LARCs) Sales and Growth Rate (2021-2032) & (k units) Figure 46. India Long-acting Reversible Contraceptives (LARCs) Sales and Growth Rate (2021-2032) & (k units) Figure 47. Australia Long-acting Reversible Contraceptives (LARCs) Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Country (2021-2032) Figure 50. Brazil Long-acting Reversible Contraceptives (LARCs) Sales and Growth Rate (2021-2032) & (k units) Figure 51. South Africa Long-acting Reversible Contraceptives (LARCs) Sales and Growth Rate (2021-2032) & (k units) Figure 52. Saudi Arabia Long-acting Reversible Contraceptives (LARCs) Sales and Growth Rate (2021-2032) & (k units) Figure 53. Turkey Long-acting Reversible Contraceptives (LARCs) Sales and Growth Rate (2021-2032) & (k units) Figure 54. Argentina Long-acting Reversible Contraceptives (LARCs) Sales and Growth Rate (2021-2032) & (k units) Figure 55. UAE Long-acting Reversible Contraceptives (LARCs) Sales and Growth Rate (2021-2032) & (k units) Figure 56. Egypt Long-acting Reversible Contraceptives (LARCs) Sales and Growth Rate (2021-2032) & (k units) Figure 57. Chile Long-acting Reversible Contraceptives (LARCs) Sales and Growth Rate (2021-2032) & (k units) Figure 58. Global Long-acting Reversible Contraceptives (LARCs) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Long-acting Reversible Contraceptives (LARCs) Revenue (2021-2032) & (US$ Million) Figure 61. North America Long-acting Reversible Contraceptives (LARCs) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Long-acting Reversible Contraceptives (LARCs) Revenue (2021-2032) & (US$ Million) Figure 63. Europe Long-acting Reversible Contraceptives (LARCs) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Long-acting Reversible Contraceptives (LARCs) Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Long-acting Reversible Contraceptives (LARCs) Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Copper Intrauterine Devices
  • Hormonal Intrauterine Devices
  • Contraceptive Implants
  • Others
Applications
  • Age 20-24
  • Age 25-34
  • Age 35-44
  • Others
Companies covered
  • AbbVie Allergan
  • ASPIVIX
  • Cooper Companies
  • Durbin
  • H & J Medical
  • HRA Pharma
  • Laboratoire 7 MED
  • Laboratoire CCD
  • OCON
  • Pregna
  • Prosan
  • Shanghai Dahua Pharmaceuticals
  • Williams Medical Supplies
  • Yantai JiShengYaoXie
  • Bayer
  • Merck

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Long-acting Reversible Contraceptives (LARCs) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Long-acting Reversible Contraceptives (LARCs) Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Long-acting Reversible Contraceptives (LARCs) Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Long-acting Reversible Contraceptives (LARCs) Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Long-acting Reversible Contraceptives (LARCs) Market Dynamics
  1. 2.1 Long-acting Reversible Contraceptives (LARCs) Industry Trends
  2. 2.2 Long-acting Reversible Contraceptives (LARCs) Industry Drivers
  3. 2.3 Long-acting Reversible Contraceptives (LARCs) Industry Opportunities and Challenges
  4. 2.4 Long-acting Reversible Contraceptives (LARCs) Industry Restraints
3 Long-acting Reversible Contraceptives (LARCs) Market by Manufacturers
  1. 3.1 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Long-acting Reversible Contraceptives (LARCs) Sales by Manufacturers (2021-2026)
  3. 3.3 Global Long-acting Reversible Contraceptives (LARCs) Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Long-acting Reversible Contraceptives (LARCs) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Long-acting Reversible Contraceptives (LARCs) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Long-acting Reversible Contraceptives (LARCs) Manufacturers, Product Type & Application
  7. 3.7 Global Long-acting Reversible Contraceptives (LARCs) Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Long-acting Reversible Contraceptives (LARCs) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Long-acting Reversible Contraceptives (LARCs) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Long-acting Reversible Contraceptives (LARCs) Tier 1, Tier 2, and Tier 3
4 Long-acting Reversible Contraceptives (LARCs) Market by Type
  1. 4.1 Long-acting Reversible Contraceptives (LARCs) Type Introduction
  2. 4.1.1 Copper Intrauterine Devices
  3. 4.1.2 Hormonal Intrauterine Devices
  4. 4.1.3 Contraceptive Implants
  5. 4.1.4 Others
  6. 4.2 Global Long-acting Reversible Contraceptives (LARCs) Sales by Type
  7. 4.2.1 Global Long-acting Reversible Contraceptives (LARCs) Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Long-acting Reversible Contraceptives (LARCs) Sales by Type (2021-2032)
  9. 4.2.3 Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type (2021-2032)
  10. 4.3 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Type
  11. 4.3.1 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2021-2032)
  13. 4.3.3 Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Type (2021-2032)
5 Long-acting Reversible Contraceptives (LARCs) Market by Application
  1. 5.1 Long-acting Reversible Contraceptives (LARCs) Application Introduction
  2. 5.1.1 Age 20-24
  3. 5.1.2 Age 25-34
  4. 5.1.3 Age 35-44
  5. 5.1.4 Others
  6. 5.2 Global Long-acting Reversible Contraceptives (LARCs) Sales by Application
  7. 5.2.1 Global Long-acting Reversible Contraceptives (LARCs) Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Long-acting Reversible Contraceptives (LARCs) Sales by Application (2021-2032)
  9. 5.2.3 Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application (2021-2032)
  10. 5.3 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Application
  11. 5.3.1 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2021-2032)
  13. 5.3.3 Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Application (2021-2032)
6 Global Long-acting Reversible Contraceptives (LARCs) Sales by Region
  1. 6.1 Global Long-acting Reversible Contraceptives (LARCs) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Long-acting Reversible Contraceptives (LARCs) Sales by Region (2021-2032)
  3. 6.2.1 Global Long-acting Reversible Contraceptives (LARCs) Sales by Region (2021-2026)
  4. 6.2.2 Global Long-acting Reversible Contraceptives (LARCs) Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Long-acting Reversible Contraceptives (LARCs) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Long-acting Reversible Contraceptives (LARCs) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Long-acting Reversible Contraceptives (LARCs) Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Long-acting Reversible Contraceptives (LARCs) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Long-acting Reversible Contraceptives (LARCs) Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Region
  1. 7.1 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Region
  2. 7.1.1 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Region (2021-2026)
  4. 7.1.3 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Region (2027-2032)
  5. 7.1.4 Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Long-acting Reversible Contraceptives (LARCs) Revenue (2021-2032)
  8. 7.2.2 North America Long-acting Reversible Contraceptives (LARCs) Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Long-acting Reversible Contraceptives (LARCs) Revenue (2021-2032)
  11. 7.3.2 Europe Long-acting Reversible Contraceptives (LARCs) Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 AbbVie Allergan
  2. 8.1.1 AbbVie Allergan Company Information
  3. 8.1.2 AbbVie Allergan Business Overview
  4. 8.1.3 AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  6. 8.1.5 AbbVie Allergan Recent Developments
  7. 8.2 ASPIVIX
  8. 8.2.1 ASPIVIX Company Information
  9. 8.2.2 ASPIVIX Business Overview
  10. 8.2.3 ASPIVIX Long-acting Reversible Contraceptives (LARCs) Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 ASPIVIX Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  12. 8.2.5 ASPIVIX Recent Developments
  13. 8.3 Cooper Companies
  14. 8.3.1 Cooper Companies Company Information
  15. 8.3.2 Cooper Companies Business Overview
  16. 8.3.3 Cooper Companies Long-acting Reversible Contraceptives (LARCs) Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Cooper Companies Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  18. 8.3.5 Cooper Companies Recent Developments
  19. 8.4 Durbin
  20. 8.4.1 Durbin Company Information
  21. 8.4.2 Durbin Business Overview
  22. 8.4.3 Durbin Long-acting Reversible Contraceptives (LARCs) Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Durbin Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  24. 8.4.5 Durbin Recent Developments
  25. 8.5 H & J Medical
  26. 8.5.1 H & J Medical Company Information
  27. 8.5.2 H & J Medical Business Overview
  28. 8.5.3 H & J Medical Long-acting Reversible Contraceptives (LARCs) Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 H & J Medical Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  30. 8.5.5 H & J Medical Recent Developments
  31. 8.6 HRA Pharma
  32. 8.6.1 HRA Pharma Company Information
  33. 8.6.2 HRA Pharma Business Overview
  34. 8.6.3 HRA Pharma Long-acting Reversible Contraceptives (LARCs) Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 HRA Pharma Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  36. 8.6.5 HRA Pharma Recent Developments
  37. 8.7 Laboratoire 7 MED
  38. 8.7.1 Laboratoire 7 MED Company Information
  39. 8.7.2 Laboratoire 7 MED Business Overview
  40. 8.7.3 Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  42. 8.7.5 Laboratoire 7 MED Recent Developments
  43. 8.8 Laboratoire CCD
  44. 8.8.1 Laboratoire CCD Company Information
  45. 8.8.2 Laboratoire CCD Business Overview
  46. 8.8.3 Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  48. 8.8.5 Laboratoire CCD Recent Developments
  49. 8.9 OCON
  50. 8.9.1 OCON Company Information
  51. 8.9.2 OCON Business Overview
  52. 8.9.3 OCON Long-acting Reversible Contraceptives (LARCs) Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 OCON Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  54. 8.9.5 OCON Recent Developments
  55. 8.10 Pregna
  56. 8.10.1 Pregna Company Information
  57. 8.10.2 Pregna Business Overview
  58. 8.10.3 Pregna Long-acting Reversible Contraceptives (LARCs) Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Pregna Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  60. 8.10.5 Pregna Recent Developments
  61. 8.11 Prosan
  62. 8.11.1 Prosan Company Information
  63. 8.11.2 Prosan Business Overview
  64. 8.11.3 Prosan Long-acting Reversible Contraceptives (LARCs) Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Prosan Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  66. 8.11.5 Prosan Recent Developments
  67. 8.12 Shanghai Dahua Pharmaceuticals
  68. 8.12.1 Shanghai Dahua Pharmaceuticals Company Information
  69. 8.12.2 Shanghai Dahua Pharmaceuticals Business Overview
  70. 8.12.3 Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  72. 8.12.5 Shanghai Dahua Pharmaceuticals Recent Developments
  73. 8.13 Williams Medical Supplies
  74. 8.13.1 Williams Medical Supplies Company Information
  75. 8.13.2 Williams Medical Supplies Business Overview
  76. 8.13.3 Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  78. 8.13.5 Williams Medical Supplies Recent Developments
  79. 8.14 Yantai JiShengYaoXie
  80. 8.14.1 Yantai JiShengYaoXie Company Information
  81. 8.14.2 Yantai JiShengYaoXie Business Overview
  82. 8.14.3 Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  84. 8.14.5 Yantai JiShengYaoXie Recent Developments
  85. 8.15 Bayer
  86. 8.15.1 Bayer Company Information
  87. 8.15.2 Bayer Business Overview
  88. 8.15.3 Bayer Long-acting Reversible Contraceptives (LARCs) Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Bayer Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  90. 8.15.5 Bayer Recent Developments
  91. 8.16 Merck
  92. 8.16.1 Merck Company Information
  93. 8.16.2 Merck Business Overview
  94. 8.16.3 Merck Long-acting Reversible Contraceptives (LARCs) Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Merck Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  96. 8.16.5 Merck Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Long-acting Reversible Contraceptives (LARCs) Value Chain Analysis
  2. 9.1.1 Long-acting Reversible Contraceptives (LARCs) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Long-acting Reversible Contraceptives (LARCs) Production Mode & Process
  6. 9.2 Long-acting Reversible Contraceptives (LARCs) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Long-acting Reversible Contraceptives (LARCs) Distributors
  9. 9.2.3 Long-acting Reversible Contraceptives (LARCs) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst